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Pre face
This report is sectioned into a summary, a
description of the hardware developed, a description of
research applications in renal hemodynamics and the
conclusions.
The sections on the development and application
are drawn from the texts of two papers prepared in
this laboratory. Section II is essentially the text
from R. D. Rader's "Telemetry Implants" for the book,
Clinical Telemetry, edited by Cesar A. Caceres for
Academic Press publication in 1973. Section III is
principally comprised of material from the paper "Renal
Paralmeter Estimates in Unrest-rained Dogs," by R. D.
Rader and C. M. Stevens. The latter paper will be
submitted for publication to an appropriate journal.
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I. Summary-
The work statement for NASA Contract No. NSR 05-018-087
committed the University of Southern California Department of
Physiology to a continuing program of research directed
toward the development of physiological instrumentation,
surgical procedures, measurement and data analysis techniques,
and a definition of flight experiments to determine the
effects of prolonged weightlessness on the cardiovascular
system of subhuman primates. The Work Statement, submitted
in the original proposal and accepted as a part of the con-
tract performance, divided the research into experiments with
both free and with partially restrained animals.
A. Contract Requirements
Specific contractual tasks were:
Task Number One. To continue development and testing of
implantable sensors and telemetry systems to detect blood
pressure, blood flow, vascular dimensions, and biopotential.
Task Number Two. To continue experimental evaluation of
sensor and telemetry systems and to identify acceptable
implant sites by a program of experiments on animals which are
affixed with implantable instrumentation systems.
Task Number Three. To acquire baseline data on possible
flight species by a program of experiments designed to acquire
cardiovascular data in relation to the subject's total env'.ron-
ment.
Task Number Four. To investigate hemodynamics, both
systemic and renal, to the adjustments seen in man and to
formulate a series of vascular measurements that would provide
the best dynamic record of blood volume shifts and hemodynamic
responses to weightlessness and simulated weightlessness.
Task Number Five. To compare cardiovascular data
obtained during the experiments with central nervous system
(CNS) data so that possible meaningful relationships between
CNS and autonomic nervous system function as revealed by the
proposed cardiovascular measures could be recognized and
evaluated.
The investigation employing restrained and unrestrained
subjects had a common goal consisting of the development and
application of sensors which would reliably and accurately
iii -c
detect parameters, such as blood pressure, blood flow, and
vascular dimensions. Stable, reliable sensors clearly bear a
very direct relationship to the outcome of any measurement and
therefore considerable work in developing the sensors was done.
The commitment to develop instruments to monitor unrestrained
subjects resulted in the development of a totally implantable
telemetry system that will operate for a duration in excess of
one year.
B. Contract Performance
Performance summaries for each respective task are
listed below:
Task Number One Performance--Development. The main
development efforts were directed toward improving the sensors
and electronics necessary to obtain measurements of blood
flow, blood pressure, and vascular dimensions. Emphasis was
placed on developing and testing blood flow probes and on
further reduction in power consumption and size of implanted
telemetry systems. Development of techniques to obtain
cardiovascular dimensions was completed through a breadboard
stage. Blood pressure, blood flow, biopotential, and power
control electronics assemblies were designed and tested and
have been evaluated by their use in chronic telemetry experi-
ments. Ground station electronics necessary for conditioning,
analyzing, and recording information were also developed and
used.
Ta..k Number Two Performance---Evaluation. In conducting
the eval ation of the sensors and electronics assemblies
extensive experience was gained iii applying the sensors and in
obtaining data from partially rest ained subjects where sensor
leads communicate through the skin. Blood pressure sensors of
the available commercial variety have undergone considerable
testing and were found to lack long term stability. Immediate
success in the area of blood flow measurements was delayed
because of structural failure of the commercially available
ultrasonic flow probes. To solve this problem we undertook
the development and fabrication of our own probes; these
probes have now undergone long term testing in telemetry
implants. As yet there remains an inability to precisely
calibrate flow for in vivo application. The results of our
efforts in developing packaging and sealing techniques for
implanted devices have been good. One telemetry system sur-
vived a total implant of four months and was removed only
because of the failure of blood flow measurements. A second
implant transmitted data for a period of 4.5 months. Failure
appeared to be a combination of lead breakage in the flow
probe and a dead battery. Typical failure is due to lead
breakage.
Task Number Three Performance--Data Acquisition. Since
national p-licies reduced the priority of orbital animal
experiments, dogs were used during the entire development and
applications as other suitable subjects were unavailable.
Experimental efforts with dogs have included measurements of
arterial pressure, blood flow at various sites, and vascular
dimensions. Several dogs have been instrumented with totally
implanted pressure and flow telemetry systems. Excellent
results in the area of pressure and flow measurements have
been obtained.
Task Number Four Performance--Cardiovascular Hemodynamics.
Experimental application dealt mainly with systemic and renal
cardiovascular studies. A means of measuring renal hemody-
namics by the use of blood flow and pressure dynamics was
conceptualized and evaluated. Because of the major role the
renal system plays in regulating body fluids and vascular
pressures, several studies were conducted on renal hemodynamics.
Application of this technique may permit an assessment of renal
function in weightlessness which has considerable advantage
relating to size, power, and weight.
Task Number Five Performance--Cardiovascular and CNM:
Data. The intent was to associate with the UCLA Brain Research
Institute in performing this por'ion of the contractual
efforts The degree to which th;s Task Number Five was
accomplished was limited by the national policy curtailin¢:
animal research in space. To a lesser degree this effortv;as
accomplished in our own laboratories in the work done on renal
hemodynamics. In this task subjective measurements of neuro-
activity was correlated with renal hemodynamic responses.
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2II. Development of an Implantable Telemetric
Data Acquisition System
A. Introduction
Care must be exercised in conducting any measurement in
order to insure that the inclusion of the sensing device
within the media does not excessively disturb the quantities
being measured. An additional problem arises in conducting
measurements on animals, as both the act of introducing the
animal into an experimental situation and the often traumatic
application of the sensing and measuring device to the subject
can produce an emotional reaction which influences the value
of the parameters being investigated. To minimize this emo-
tional reaction, drugs are often administered with the result
that the parameter under investigation may be significantly
altered. In many cases neither option, the application of
the measuring device without the benefit of drugs, nor the
administration of drugs to control the subject's reaction to
the application of the device yields a valid experimental
situation. An escape from this experimental dilemma is avail-
able in the use of biotelemetry. The subject can then be
instrumented under anesthesia and after sufficient time for
recovery can be monitored under more natural conditions. The
application of telemetry as a tool for improving measurement
techniques is expanding and is currently credited as a major
means of acquiring data from near-normal, unrestrained,
unanesthetized animals subjects (Rader et al., 1968).
Experimental techniques in unrestrained ambulatory
animals are further improved by -he use of totally implant id
telemetry devices. It is the problem of the designer to
achieve a' telemetry device meeting conditions relating to
size, operating life, accuracy, and reliability which satis-
fies the experimental requirements. The necessity for implant
often imposes stringent design conditions. An equipment
package size compatible with subject size is a major control-
ling factor. With a fixed package size, operating life can
only be increased by limiting power consumption; thus the use
of low power electronics is necessary and some form of trans-
mitter control is indicated. Reliable maintenance-free
operation is also very important; as once the unit is implanted,
repair can generally be conducted only by entirely removing
the implanted electronics package. Measurement stability is
also of major importance as frequent calibration cannot be
readily performed once the implant has been achieved.
3In an efficient measuring system, parameter selection is
often made on the basis of maximum information yield relative
to constraints such as minimum power expenditure, acceptable
accuracy, and minimization of size. In cardiovascular
research parameter selection is biased by the fact that knowl-
edge of blood pressure and blood flow is required for appre-
ciating the hemodynamics of the entire circulation or of any
particular segment. Measurement of these two parameters
yields considerable direct information and other parameters
can be calculated. In addition to heart rate, dynamic pres-
sure measurements yield information about the heart contractil-
ity and the elasticity of the vessels. Dynamic blood flow
measurements conducted on the ascending aorta yield cardiac
output in liters per minute. From the ratio of mean pressure
to mean flow an estimate of mean flow resistance can be
obtained; and since this resistance is modulated in part by
nervous system inputs, a feeling for the involvement of the
central nervous system in cardiovascular regulation can be
developed. Data analysis is further improved by electronic
means of achieving division, integration, and differentiation.
Totally implantable pressure-sensing techniques have
been quite well developed in the last decade and currently
enjoy modest application in biological research. On the
other hand, totally implantable techniques for measuring blood
flow have not been equally well developed. The currently
popular electromagnetic techniques require considerable power
and extensive circuitry and yield a very low-level voltage
analog of flow. Long term stability is inadequate to allow
definite placement of zero flow without occlusion. The
sensitivity also varies with vese-l wall thickness and her.ato-
crit value. On the other hand, ultrasonic techniques are -
comparatively new to the field of blood flow measurement and
do not enjoy the confidence extended to electromagnetic means.
A major criticism leveled at all existing ultrasonic measuring
techniques relates to the inability to quantify the results.
Less basic problems but nevertheless critical ones also
exist (Rushmer, 1966). For example, in acute application the
ultrasonic probes often lose contact with the vessel wall and
produce erratic readings. Acute use of the probes is possible
by careful application of gels or foams which insure good
contact of the crystals with the vessel wall. On the positive
side, the probes are lighter, conditioning circuitry is often
not extensive, power requirements are low, and the unamplified
signal level is for some versions two orders of magnitude
above that produced by electromagnetic techniques. Zero
4stability, though not optimum, is acceptable. For chronic
application problems associated with poor vessel wall contact
are obviated by the tissue growth in and around the probe.
Calibration for either the electromagnetic or ultrasonic
technique is tedious, difficult, and generally inaccurate, and
therefore it is not the deciding factor in selecting the
optimum sensing device.
The ultrasonic technique was preferred in our labora-
tories for extensive implant application principally because
of the -low power requirements, lighter probe, and less exten-
sive circuitry requirements. The specific ultrasonic tech-
nique used in this development was selected over others
because of its inherent simplicity and its comparatively
greater basic analog signal level.
B. Design Problems and Goals
The effectiveness of the analysis of the cardiovascular
'system is greatly enhanced by making simultaneous measures of
flow and pressure, for when they are taken together they
yield impedance, a third important variable. Specifically
flow is equal to pressure divided by impedance; thus if pres-
sure and flow are measured, the impedance can be calculated.
The use of implanted sensors to detect flow and pressure and
the use of external electronics to transmit this data to
remote recording sites is quite common (Franklin et al., 1971;
Rader et U1., 1967). However the technique has several prcb-
lems associated with it. The possibility of infection where
leads emerge through the skin is high. A degree of contro.l
is possible by the use of antibiotics and by aseptic tech-
niques. Protection of the sensor leads and attached equipment
is very difficult. A solution to these troublesome problems
is not an absolute requirement as extreme care will allow
useful data to be obtained over a considerable duration.
However the application of an implantable telemetry device
that eliminates these problems without creating added problems
has a clear experimental advantage. Fortunately in practice
few new pzoblems are created by total implants. A potential
hazard is tissue reaction to the implant; however, in actual
practice it has not been a problem. Many materials accept-
able for implant have been identified and the equipment size
can be reduced to acceptable limits (Brown et al., 1971;
Rader, 1971). At the crux of the matter are the problems of
obtaining seals at connectors and sensors and achieving
acceptable stability with low power expenditure. The matter
of sealing can be solved by good practices. The remaining
5problems are related to achieving sufficient operating life
with the limited energy available to qualify the system for a
long term implant and to realizing sufficient stability to
make the device useful. It is to this last problem that the
designer must address himself.
The current state of energy sources limits the total
operating life to a rather short period if continuous opera-
tion is attempted. Fortunately the nature of many experiments
does not require continuous data. Sufficient clarity can
often be obtained by sampling; thus one minute of data each
hour might be adequate. Not only does this prolong the use-
ful lifetime of the device, but it trims the data to a manage-
able quantity. With the expedient of controllable or at least
programmed transmission a package size acceptable for implant
and operational for several years can be achieved. Represent-
ative techniques for implantable systems are presented by
Rader (1971) and Fryer (1970).
The design problems are not simple and as in most
situations compromises are necessary. To extend the operating
life micropower circuitry must be employed. In addition to
limiting transmission time, other current-saving techniques
such as duty cycling of amplifiers and oscillators must also
be incorporated. For many cardiovascular measurements inte-
grated circuits of sufficiently low power consumption are not
available, and one must resort to a discrete component
approach or become involved in a hybrid development which
often produces only a small decrease in volume and power con-
sumption at considerable economic :ost. The discrete compo-
nent appioach is necessary for many developments.
There is an abundance of telemetry techniques many of
which have a particular advantage for certain applications.
An FM/FM mode was employed in the past and developed under
government contracts with the requirement that the standard
IRIG systems be used. The directive was sound as standard
receiving and demodulating equipment exists and the number of
channels required for effective animal experiments does not
exceed that available. The trend was thus established and no
compelling reason has existed to force a change. A typical
data channel consists of a sensor, a signal conditioner, and
a sub-carrier oscillator. Common to all channels is a carrier
oscillator, a power supply, a regulator, and a power control-
ler. The stability of all modules in the package influences
either the measurement accuracy or the reliability.
6Stability, though often incompatible with low current
operation, is of critical importance as calibration cannot
readily be performed once implant has been achieved. Thus the
stability of the slope (sensitivity) and the intercept (base-
line) must be held to acceptable limits for months. Sensor
aging, component aging, and supply voltage variations contrib-
ute to instability. Negative feedback can be employed to
control component aging and voltage regulation can be used to
reduce the sensitivity to supply voltage variation. Realiza-
tion of sensor stability is definitely the most difficult
problem and can be dealt with effectively only by sound sensor
design and application. This problem is further complicated
by the requirement for small size sensors and their use in a
chemically hostile environment. Thermal effects can often be
eliminated by specific compensation of the combined sensor
and circuitry but there is no easy solution to the long term
drift problem.
C. Instrumentation Design
In this-development one of the more important factors
has been the realization of low current operation in conjunc-
tion with small size and good thermal and time stability. The
end product of the electronic development has been a frequency
modulated subcarrier oscillator proportional to either pres-
sure, flow, or biopotential signals.
The cardiovascular implant system utilizes one 9.8-volt,
160 milliampere-hour mercury cell battery with a voltage
regulator. Transmission is initiated by an RF signal and
terminates automatically after a','reset interval. A potertial
of 800, 8-minute transmission episodes is available. By this
expedient in concert with the use of low power electronics-
an experiment with a potential duration in excess of a year
can be conducted.
1. Carrier and Subcarrier Oscillator. The carrier
oscillator is a single stage LC oscillator displacing approxi-
mately 0.15 cubic inches (Fig. 1). It requires less than
1 milliampere at 6 volts to deliver sufficient power for a
substantial transmission distance. A combination shield and
antenna developed for the oscillator makes it relatively
immune to frequency changes caused by proximity to objects.
Average handling produces frequency changes in the order of
40 kilohertz at center frequencies between 215 and 260 mega-
hertz. A temperature change from 50 to 120 degrees Farenheit
causes a frequency shift of approximately 150 kilohertz.
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8Complete immersion in water shifts the frequency by 40 kilo-
hertz. In most cases the shift is well within the automatic
frequency control of the receiver used. The oscillator will
operate with all standard IRIG subcarrier frequencies. The
immunity of the oscillator to proximity effects allows the
transmitter to be placed directly on or within the subjects.
Special IRIG frequency subcarrier oscillators were
employed which were independent of temperature, supply voltage,
and load changes and have inherent frequency modulation limits
for prevention of overmodulation into adjacent channels (Rader
and Griswold, 1965). The oscillator is functionally illus-
trated in Fig. 2 (top). The characteristic equation for the
oscillator can be found by considering each loop separately
and adding the results. The loop equations in terms of trans-
fer functions and gain factors are:
A = (A + B) G1 K1
B = (A + B) G2 K2
(1)
Addition of these equations results in
K 1 G 1 + K2 G2 = 1
(la)
Oscillation is possible when Eq. la is true. Gain factors
K1 and K2 can be controlled and G1 and G2 are frequency-
dependent transfer functions. The frequency at which Eq.la is
zero is influenced by both the gain factors and the proper-y
of the transfer functions. With fixed transfer functions
single-ended modulation is possible by control of either K1 or
K2 and double-ended modulation possible by control of both K 1
and K 2. In the circuit (Fig. 2, center) the gain is con-
trolled by the bias on transistors Q1 and Q2. Equation la
also reveals limit frequencies beyond which the oscillator
cannot be modulated regardless of the variation of K1 or K2.
These limi.t frequencies.are defined by transfer functions
G1 and G2. Proper selection of G1 and G2 prevents overmodula-
tion into adjacent channels and subsequent loss of information.
A brief analysis of an ideal circuit similar to the one shown
in Fig. 2 is undertaken below. The transfer function for the
parallel T.networks (Landee et al., 1957) can be written as
Figure 2. Subcarrier Oscillator.
(Top) Functional Diagram
(Center) Circuit Diagram
(Bottom) Performance Curve
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Eo
1 - E1-
X (W) + j B
X (W) + j C
G = Eo - Y (w) + j B
E
2
Y (W) + j C
where B and C are constants.
The definitions of X and Y are
X = - ; = l/R1 C1
Y - ~2 - ; 2 = 1/R2 C2
Substitution of these parameters into Eq. la gives:
K1 X + K2 Y + j 1
X+jC Y+jC
For this equation to be true, the left side must have
imaginary term. Equating the imaginary part of Eq. 4
zero gives
(2)
(3)
(4)
no
to
K 1 X (B - C) (y2 + C2 ) + K2 Y (B - C) (X2 + C2 ) = 0
(5)
A general solution to Eq. 5 is difficult; therefore threei
special cases will be considered.
Case 1 K 2 = 0 K 1 O0
Setting K 2 to zero in Eq. 4 and equating the imaginary part of
the left side to zero gives
X (B - C) = 0
(6)
If (B - C) is not zero, then X must be zero. Therefore,
Wl _ w = o
w W 1
(7)
11
12
Solution of Eq. 7 gives
= W 1
Case 2 K 1 = 0 K 2 Z 0
By the same approach it can be shown that w = 2 when K1 = .
Case 3 K1 = K2 = K
When K1 = K2 = K, Eq. 5 simplifies to
K (B - C) (X + Y) (X Y + C2 ) = O
(8)
One solution is found by allowing X + Y to equal zero.
This condition results in
W1 Wl W W2- + - = 0
(9)
Solution of Eq. 9 gives
= '/ 1 W 2
(10)
The curve in Fig. 2 (bottom) illustrates the modulation
sensitivity and limit frequencies. To provide good linear:ity
-the lim't frequencies are generally set at about the + 10%
point on the standard IRIG channels. Frequency variation due
to temperature variation is small due to the use of tempera-
ture insensitivity components. The oscillator requires 100
microamperes at 6 volts. The unloaded output is a 3-volt
sinusoidal signal and requires little filtering for elimina-
tion of higher harmonics. The transfer functions can easily
be designed to produce oscillation at center frequencies from
400 Hz to 22 KHz with limit frequencies at + 10% of center
frequency. Frequency-to-voltage conversion has been achieved
by use of the standard commercial discriminators or by the use
of phase-lock loop systems built around available integrated
phase-lock loop circuits.
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2. Power Controller and Voltage Regulator. In order
to realize reliable implantable devices that will oeprate for
several months it is necessary to limit transmission time to
a small percentage of the intended implant life. One solution
is to employ a radio frequency actuated switch that enables
transmission time to be controlled by the investigator.
Transmitted energy is received and detected by an inductance
capacitance tuned circuit in the base circuit of a high gain
amplifier. The amplifier turns on a silicone control switch
which remains on for a predetermined interval. This mode of
operation allows command of transmission and insures against
rapid battery decay due to accidental turn on by extraneous
sources.
Figure 3 (top) illustrates the circuit developed for the
control function. Transistors Q1 and Q2 comprise a high gain
amplifier which amplifies the signal induced across the tank
circuit. This signal is rectified and employed to turn on
SCS1 to initiate transmission. Capacitor C4 then charges,
and through Q3, this charge turns on SCS2, which through its
influence on Q4 turns the entire system off and terminates
transmission. The function of DA is to remove the remaining
charge on C4 after transmission is terminated. This allows a
near-normal transmission time if the system is immediately
reactivated. The duration of transmission is controlled by R9
and can be set conveniently anywhere between a few seconds
and 20 minutes.
The regulator in the circuit is shown in detail at the
bottom ir Fig. 3. Basically the regulator consists of a h:.gh-
gain, low power amplifier 'referenced to a constant voltage
source. Transistor Q1 is employed as a series regulator which
in turn is controlled by Q2 and Q3. Q2 senses any voltage
change across the load and through its influence on Q3 and Q1
corrects for this change. The majority of the current used
by the regulating amplifier is directed through the voltage
reference, eliminating a separate current path for this func-
tion. Q4 compensates for a 50 through 120 degree Farenheit
environmental temperature change. The regulator consumes
approximately 1.5 milliwatts of power.
3. Blood Pressure-Signal Conditioner. Blood pressure
is detected by the use of chronically implanted miniature
pressure sensors (Konigsberg, 1966). The sensor body is
unalloyed titanium 6.5 millimeters in diameter and 1 milli-
meter thick. This material is highly corrosion-resistant,
allowing long term direct contact with body fluids. Four
14
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Figure 3. (Top) Circuit Schematic of Radio
Controlled Switch.
(Bottom) Circuit Schematic of Voltage Regulator.
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semiconductor strain gauges connected in a conventional four-
arm bridge are bonded to the inner surface of the small
pressure-sensing diaphragm. Positive pressure on the face of
the transducer causes resistance changes that are transformed
to a voltage change. The sensor is quite sensitive producing
approximately 30 mv/300 mm Hg, when used as suggested by the
manufacturer. Its frequency respon3e is well in excess of
that required to obtain dynamic blood pressure measurements and
its temperature characteristics can be determined and properly
handled.
Figure 4 illustrates a circuit schematic that transforms
blood pressure variations to voltage variations and sequen-
tially produces frequency modulation of a subcarrier oscillator
proportional-to pressure. Conditions dictating the circuit
design relate mainly to power consumption and reliability.
Modest power consumption in concert with high sensitivity was
achieved by pulsed operation of the resistance transducer and
by utilization of low power auxiliary circuitry.
The circuit consists of a differential input voltage-
controlled oscillator with active elements Q5 and Q6; a pulse
generator consisting of active components Q1, SCS1, and Q4;
and a pulse-amplifying circuit consisting of Q2 and Q3. The
output of the voltage-controlled oscillator turns SCS1 on,
which turns Q4 on, placing the supply voltage across the
pressure sensor. Transistor Q1 turns on after a delay estab-
lished by the RC time constant anc turns SCS1 off. The effect
is then an application of a narrow voltage pulse to the pres-
sure sensor on each positive excu'rsion of the voltage-
controlled oscillator output. The difference between the
pulse levels at the output of the oressure sensor is amplified
by Q2 and Q3 and filtered by the RC networks connected to the
collectors. The resultant DC voltage which is proportional to
pressure applied to the transducer is employed to modulate the
voltage-controlled oscillator. The major advantages of this
mode of operation are high sensitivity, low current operation,
and the realization of overmodulation protection by the use
of a subcarrier with frequency limits.
4. Flow Concept. The block diagram at the top in
Fig. 5 illustrates a prototype system which is considered
first to aid in understanding the concept (Rader, 1971; Plass,
1964). Piezoelectric crystals resonant at 5 MHz are posi-
tioned diagonally across a flow section. The crystals are
excited in phase opposition by a continuous 5 MHz signal. The
ultrasonic energy generated by crystal X1 and transmitted
16
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downstream causes a mechanically-induced voltage to sum with
the electrical excitation voltage on crystal X2 . The same is
true for the energy generated by X2 and received by X 1. These
cross-coupled signals are either delayed or advanced in time
and are therefore modulated in phase relative to the excita-
tion voltage in proportion to flow velocity. Specifically in
an ideal ca3e where exact balance exists and only the excito-
tion voltage and the first incident term are considered
voltages el and e2 are:
el = V Ke coswt - Ke Ks V cos (wt + y + 8)
e2 = V Ke coswt + Ke Ks V cos (wt + y - 8)
(11)
where the cross-coupled mechanically-induced components are:
- Ke Ks V cos (wt + y + 0) (energy from X2 impinging on X1)
+ Ke Ks V cos (wt + Y - 0) (energy fran X1 impinging on X2)
(12)
FWhere the parameter Ke is an attenuation factor related to
the impedances of the source and the crystals, and the con-
stant Ks is an attenuation factor related to distance and to
the material between crystals and to the Q of the crystals, 0
is the phase shift caused by the flow; and y is the phase
shift related to the probe geometry. The idealized output
voltage is then
es = el + e2 = 2 Ks Ke V` sin 8 sin (wt + y)
(13)
The magnitude of the signal voltage is thus a function of
sine 8, the coupling coefficient Ks, and the effective crystal
drive voltage KeV. The value of e and y can be derived by
consideration of the geometry and the flow velocity. In par-
ticular, as derived from Fig. 5, the time required for energy
to propagate from crystal Xlto X2 is:
1-2 d-Q dT 1- d2 dx + dx + 
C C + v cos C
(14)
o
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Where C is the velocity of the acoustical energy in the
medium, a is the angle between the flow velocity and the
ultrasonic energy propagation direction, v is the velocity of
blood flow which for purposes of analysis is assumed to be
blunt, and d the distance between crystal faces, and 9 the
distance from inside of the vessel to each crystal face.
Division of
C + v cosa
(15)
results in
_ cosa (v cosa 2 osa (16)
C C C
By valid assumption that
v cosa , 1V COS << 
C.
(17)
the squared and higher power terms of the series can be
neglected without serious error to give the second term in
Eq. 14 equal to
d - 2 _ (d - 2k) v cosa
C C2
(18)
The first and third terms of Eq. 1l, combine to yield 2Z and
when this is added to the second term one gets
_ d (d-2Z) v cosa
T1-2 C C2
(19)
The total phase shift between crystal X2 excitation voltage
and the mechanically-induced signal voltage on crystal X2 from
cross-coupled energy from crystal X1 is T1-2 divided by the
period of the excitation frequency
2 r f d 2 Xr f (d-2k) v cosa
C 2
(20)
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and thus
2 T f d 2 E f (d-29) v cosa
Y C e2
C
(21)
The output voltage then becomes
es = 2 Ke Ks V sin 2 T f (d-29R) v cosc sinwt + wd
C2 C (22)
The factor wd/C is related to probe dimensions and excitation
frequency and therefore contributes no information regarding
flow velocity. The function 2 f f (d-2k) v cosa/C2 contains
the useful information and produces amplitude modulation of
the signal proportional to the sine of the function. For
convenience let the following identity apply:
E = 2 Ke Ks sin 2 T f (d-2k) v cosa
2C
(23)
Since d-2k = D/sina , Eq. 23 becomes
E = 2 Ke Ks sin 2 T f D v cota
C2
(23a)
For a small value of velocity the phase shift produced is
small, allowing sine 0 to be replaced with 0, and with
a = 450 the ideal peak signal vo'tage is
4 Ti f Ke Ks V Dv
E =
(24)
For typical probes and probe-excitation voltages of 3 volts
peak the value of Ke Ks V has been found to be nominally
0.5 volt. With f = 5 MH and C = 1.55 x 105 cm per second,
the theoretical signal level is then:
E = 13 Dv x 10 volts/cm2 /sec
(25)
For flow measurement on a 1 centimeter internal diameter
vessel, assuming velocities of 100 cm/sec, a 130 mv signal can
be realized. This can be contrasted with an electromagnetic
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level of 0.3 mv for the same position and a pickup signal on
the order of several tens of microvolts for the back-scatter
ultrasonic technique (Rushmer, 1966). The selection of the
1800 quiescent phase difference between the pickup voltage
results in excellent sensitivity. If the flow velocity
exceeds the value which makes e = r/2, the flow velocity
becomes indeterminate. In actuality, the flow velocity is
quite low producing a phase shift of approximately 0.1 radians.
Negative flow can be detected by proper circuit manipu-
lation. Proper adjustment of reactive balance circuits will
produce an output signal at zero flow which increases with
positive flow and decreases with reverse or negative flow.
For the case of exact balance, the output signal as a function
of flow velocity would appear as an absolute value. If the
reactive balance is properly adjusted, the curve can be
shifted to the left to produce an absolute value function
with shifted axis. In this case, for zero velocity, the out-
put has some positive value and increases for flow directed
toward X1 to X2, and decreases for flow directed from X2
toward X1 . A sufficiently large reverse flow will produce
increasing outputs. This poses no great problem as the magni-
tude of reverse flow is typically small. Proper phase detec-
tion of the output signal can also be used to realize the
ability to detect reverse flow. This is perhaps the desired
technique as it does not require special care to insure that
the system is in a proper operating region. For a bench
system modern integrated circuits yield a simple means of
detecting phase. However these circuits are not optimum for
implant, and therefore systems employing strict phase shift
techniqut:s are not discussed in this chapter. The continuous
operating mode is somewhat unstable and consumes excessive
power and for these reasons is not optimal for implant. An
optimum concept for implant appears to be a combination of
pulsed operation for minimum power consumption and amplitude
limitation for prevention of spurious amplitude variation from
contaminating the flow signal. In this mode the crystals are
pulsed in phase opposition for approximately 1 microsecond and
measurements are conducted only or. the received energy at each
crystal. Appropriate gating and timing circuits are required
to produce correct operation.
5. Flow Circuit. The circuit required to perform this
operation as described is shown in Fig. 6. The output of a
subcarrier oscillator is connected to the cathode gate of
SCS1. When the gate voltage rises above 0.7 volt, SCS1 turns
on and forward biases the 5 mc oscillator transistor Q3 and
Figure 6.
Schematic.
Blood Flow Signal Conditioner
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the 5 mc crystal driver amplifier transistors Q1 and Q2.
Coincidental with the SCS1 turn on, capacitor C6 starts to
charge through R10. When Q4 is sufficiently forward biased,
SCS1 turns off. The pulse generated by SCS1 is limited by
the series diode stack D2 and R 1 1. This constant amplitude
pulse is deposited on C8 which in turn charges C 1 0 through
R14 and R15. turning on SCS2. The delayed pulse generated by
SCS2 is then used to gate both limiting amplifiers and the
output amplifier just prior to the arrival of the incident
acoustical energy at each crystal.
The on time of the amplifiers is controlled by the time
constant determined by R2 1 and C1 2 . The component network
connected to the emitter of Q1 4 rectifies and filters the
amplified RF signal, producing a DC signal proportional to
flow velocity. The output is then connected to a subcarrier
oscillator to produce frequency modulation proportional to
flow velocity. The synchronization signal is also derived
from the subcarrier oscillator.
For an ideal case where the crystals are well matched
and the summing resistances are equal, the response curve is
an absolute value function and reverse as well as forward flow
appear as a positive voltage. A small capacitor placed in
parallel with R2 or R3 , depending on the probe, results in
improved measurement as the pickup signal on X2 then leads the
pickup signal on X1 ; and thus for zero flow, there appears to
be a flow from X1 toward X2. Therefore at zero flow there is
a positive voltage getting more positive for forward flow and
less positive for reverse flow. Since the maximum negativte
flow is quite small, only a slight adjustment is required 6o
acquire the ability to measure reverse flow.
D. Stability Consideration
Pressure stability is influenced by both biologic and
electronic factors. Growth of tissue over the implanted
transducer with consequent high velocity lateral flow can
induce some error in pressure reading. Comparison of pressure
measured by cannulation with that obtained by the transmitter
yields an adequate calibration that incorporates both the
tissue growth variable and the lateral flow variable.
The major stability problem is related to the long term
drift of the transducer. Franklin et al. (1971), Konigsberg
(1971), and Rader and Meehan (1971) have observed and reported
long term drifts in these transducers. The initial work,
still incomplete, indicates that with premium transducers one
may have a baseline drift of 6 mm Hg per month and a sensitiv-
ity drift of approximately ± 3% per month. The combination
can then lead to a 12 mm Hg error over the period of a month.
Temperature instability is not serious as the transducers
have an output reasonably independent of temperature and also
because tha application is in a veri narrow temperature range.
So far a full appreciation of the long term drift is not
available. At the moment the fact of the matter is that cali-
bration after implant will be required periodically to confirm
pressure readings. In implant application, if the long term
drift is sufficiently small to prevent off-scale readings in
the course of a year, one may well have to be content.
The flow device described suffers from two potential
inaccuracies: one is purely electronic and therefore can be
either fully eliminated or neutralized by compensation; the
other stems from the inability to precisely measure the
internal diameter of the vessel, and from the fact that the
velocity profile is not blunt and in fact may be variable.
It is of some importance to realize that the output
voltage is in terms of the product of blood flow velocity and
the blood flow cross-sectional area. The quantity of flow
can be calculated from
c 3 1TD2v
Sec 4
(26)
From an ideal theoretical consideration of the output signal
and with amplification included afi:er summation, it is pos-
sible to write the ideal peak voltage as
E = A 4 w f Ks Ke V Dv cota
C2
(27)
A combination of Eqs. 26 and 27 yields an equation in which
the quantity of flow is in terms of a measured voltage and
several system parameters, some of which can be assumed to be
constant. The flow is thus
E C2 D tanaQ = .
16 f Ks Ke V Ao
(28)
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In general the only constants in the equation are the coeffi-
cients, the frequency f, and the gain A. The velocity C of
ultrasound in tissue and body fluids varies with temperature,
chemical constituents, and viscosity (Heuter and Bolt, 1955).
The diameter D can be expected to vary with pressure, neural
control, autoregulation, and mechanical events. The coupling
coefficient K s varies with the vessel wall thickness and the
vessel contact, the chemical constituent of the conducting
media, and the temperature and viscosity of the coupling
media. The effective crystal drive voltage Ke V can be
expected to vary with external components and with crystal
loading which is influenced by the quality and temperature of
the media.
For fixed environmental conditions it is possible to
measure and assign fixed values to C, D, Ks, and Ke V. Due to
improper knowledge of the precise values at this fixed envi-
ronmental condition the resulting constant would likely be in
error by ± 10%, as measurement of the diameter is probably
only within ± 5% and other imprecise values contribute the
additional 5%-. With the assumption that the value of E can
be measured very accurately, the calculated sensitivity
inaccuracy is bounded by approximately ± 10%. The sensitivity
inaccuracy associated with the back-scatter technique where
the Doppler frequency is related to flow velocity (Franklin
et al., 1964) by
2 Fe v cosaF =
C
(29)
cannot be less than approximately ± 10% if it is assumed that
the diameter can again be measured to ± 5% and the parameters
Fe, cosine a, and C are determined exactly. Thus the inter-
ferometric technique appears to be at least an equivalent
method in regard to absolute sensitivity at a given stable
environmental condition.
An additional important question can be asked concerning
the extent to which the sensitivity and the zero baseline will
vary with the changing chemical and thermal environments. It
has previously been developed that measurement stability is
related to the properties of the crystals and their mounting
structure; to the component stability of the electronics; and
to the variation of velocity and attenuation of ultrasound in
tissue and body fluids with temperature, pressure, and chemi-
cal composition. It is unlikely that the drive voltage on
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each crystal would be equal in either phase or magnitude
because of differences in mechanical loading; it is equally
improbable that each crystal would respond equally to identi-
cal acoustical inputs because of unequal mechanical loading.
For the continuous mode of operation the general equation for
the sum of el and e2 can be written for magnitude and angle
differences as:
e = Kel V1 cos (wt + '1) -- Ke 2 V2 cos (wt + '2)
+ Kel Ks2 V 1 Cos (wt + y + p1 1 80)
- Ke2 Ks1 V 2 cos (wt + Y + '22 + 0)
(30)
Where Kel and Ke2 are related to the impedance of the crystals
and the source, Ksl and Ks2 are related to the attenuation
factor of the media, to the quality factor of the crystals,
and to the distance between crystals. The angles '1 and '2
are associated with the impedance of the crystals and source
and *11 and '22 are angles associated with the mechanical
response of the crystals to incident energy.
For purposes of analysis it is convenient to consider
magnitude and phase imbalance separately and to consider the
results as a worst case to obtain the maximum expected error.
For magnitude consideration only, it is assumed that
P1 = P2 = P11 = P22 = 0.
This gives
es = (Kel V1 - Ke2 V2) coswt
+ Kel Ks2 V1 cos (wt + Y - 0)
- Ke2 Ksl V 2 cos (wt + Y + 0)
(31)
The signal voltage e
s
is the summation of four vectors, all of
which are comparatively large and are variable with drive
voltage, crystal and media properties, and component stability.
Two of these vectors vary in phase with flow because of the
flow-related term in their angle. The result of this angle
variation is a nonlinear amplitude variation of the resultant
signal voltage with flow. The first step toward eliminating
this nonlinearity is to adjust V2 in Eq. 31 such that the first
term is zero. If this is done with the condition imposed that
11-, 2, '11, and '22 equal zero, the equation simplifies to
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e
s
= [A12 + A22 - 2 A1 l A2] + 4 Al A2 sin2 8 sin (wt + $)
(32)'
where p is the angle of the composite vector and
Al = V1 Kel Ks2 and A 2 = V2 Ke2 Ksl. Thus only if Al = A2 = A
whence
es = (2A sin 0) sin (wt + Y)
(33)
does one achieve a truly linear response with a small angle
of O.
In Eq. 32 the first term in brackets under the radical
produces a residual voltage related to the imbalance of Al and
A2 but unrelated to flow. The second term in brackets under
the radical is the flow related term. Zero residual voltage
is produced only if Al = A2. The sensitivity is also directly
proportional to the value of Al and A2. For variation of Al
and A2 around an arbitrary value of A by ± 10%, the residual
voltage or zero baseline remains quite constant and close to
zero. The sensitivity however varies by as much as 20%. A
reciprocal change in Al and A2 tends to stabilize the sensi-
tivity, yet affects the zero stability very little. The
linearity remains quite good throughout. Factors contributing
to variance in Al and A2 are drive voltage changes, crystal
property changes, component value changes, and media property
changes, all of which can be functions of time, temperature,
and voltage.
In addition to its direct E fect on the sensitivity by
virtue of its influence on 0, a change in frequency also
affects all K values and thus Al and A2. The crystal response
is similar to a resonant circuit and thus the K values are
also dependent on frequency. Fortunately this can be precise-
ly fixed by crystal-controlled oscillators. Sensitivity
changes produced by velocity changes are squared and thus can
contribute markedly to accuracy. The velocity is related to
temperature, pressure, chemical concentration, density, and
compressibility; thus one must be careful in assigning a
constant to this parameter. Fortunately with most conditions
velocity variation is quite small; for example, from water to
blood the velocity change is about 3%, and the velocity
variation in blood with temperature is about ~.3% per degree
Centigrade and thus its affect on the output can be neglected
for normal operation. The attenuation of the ultrasonic
signal is also quite variable with temperature and also from
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media to media. For a similar condition of temperature and
distance, the signal received in the blood is about 75% of
the corresponding condition in water. The change in attenua-
tion of sound in water with temperature is negligible and in
blood at approximate body temperature is about 2% per degree
Centigrade. Since the output is directly proportional to the
level of the cross-coupled signal without compensation one can
expect a signal inseparable from flow of about 2% of full-
scale per degree Centigrade.
Undesirable phase shift errors stemming from many of the
same conditions that introduce magnitude-related errors also
contribute to inaccuracies. For this analysis it is assumed
that all magnitude differences have been nulled and the phase
difference exists in the crystal excitation voltage due to
off-resonance operation of each crystal and unequal phase
shift properties of conditioning circuits.
With these simplifications the output signal becomes:
es = VKe [cos (wt + 1) - cos (wt + 2)]
+IK Ks V [cos (wt + y + 1'11 - 8) - cos (Wt + Y+ P2 2 + 8)]
(34)
With no flow (0 = 0) two residual voltages exist because of
angle imbalance due to out-of-phase drive and out-of-phase
detection. This residual output is a function of all angles
and only remains constant if the increment in Q1 equals the
increment in ~2, and the increment in P11 equals the increment
in ~22. By adjustment of the inp;.t, '1 can be made equal to
P2; and thus the first term cancels, leaving one residual:,
voltage related to unequal phase shifts associated with the
cross-coupled energy. For any particular condition the
effects of these imbalances can be nulled; however, to obtain
thermal and chemical stability, the value of '11 and '22 must
track very closely. The value of all angles '1, '2, l11 and
'22 are telated to frequency, temperature, chemical composi-
tion, and mechanical loading of the crystal. An analytical.
description of these angles is difficult to obtain, however,
since the effect of this nontracking is a relative phase shift
between the two crystal voltages; an experimental evaluation
can be made by simply observing the phase shift as a function
of the required condition. Such a test reveals that
temperature-induced relative phase shift between crystal
voltages is very small. However, the ultimate effect this
change has is substantial because of the large common mode
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excitation signal (VKe in Eq. 34). The direction of this
change is entirely a function of relative crystal properties.
Many of the inaccuracies associated with undesirable
amplitude and phase changes induced by alterations in crystal
properties and the attenuation properties of the conducting
media can he reduced by proper conditioning of the signals
derived from each crystal. The parameter Ke Ks V in Eq. 34
is not in reality a constant as it is dependent on both
crystal and media properties. However this dependency can be
reduced by limiting the signal voltage from each crystal prior
to phase detection. The large common mode signal can be
eliminated by pulsing the crystals.
The ultimate in stability at the cost of additional
complexity but with considerable reduction in power consump-
tion is achieved by a combination of pulse- and amplitude-
limiting techniques. In this approach each crystal is excited
for a brief period, usually about 1 microsecond, and measure-
ment is conducted only on the cross-coupled energy to each
opposite crystal. The signal from each crystal is after
limiting.
e
l
= -V coswt + ~1 + 0
e2 = V coswt + ~2 - 8
(35)
addition gives
es = - V v 1 - cos".2 - 41 - 2 8
0 = 2 f D v
C2
(35a)
Common mode phases such as would occur due to changes in
velocity of sound or probe dimensions and as represented by W
do not affect the relative phase, and in this regard, do not
affect the output signal. To the degree that these variables
are contained within the function 0, they do affect the
measurement stability. From Eq. 35a it can be determined how
variation in sound velocity, vessel diameter, and frequency
affect the measurement stability. The variation in V can be
held to very small values, thus substantially reducing the
dependency of the output voltage to random amplitude
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variation. For practical applications it can be assumed that
f is constant. Sound velocity in body fluids varies by
approximately 0.6 meter/sec/C° , thus over a 10-degree span
the velocity would increase by 600 cm/sec. On this basis,
the error contributed by velocity variations due to tempera-
ture can be neglected. Velocity change associated with
chemical composition is small, being on the order of 3% from
pure water to blood, and this can possible by neglected for
the modest hematocrit changes that are to be expected.
The major error stems from a differential phase imbal-
ance caused by resistive and reactive component value changes
in the crystal with temperature and loading. As illustrated
in Fig. 5, an electronic equivalent of each crystal is a
series combination of resistance and reactance. To the effect
of these components can be added the effect of the source
impedance. The crystal components RE and XE vary with tem-
perature, loading, and age. Generally both crystals tend to
change in the same manner, but with unequal magnitudes, with
the result that some residual phase change exists. For a
well-defined temperature and loading condition which one
expects in implant cases the differential phase change repre-
sented by 1l - ~2 is acceptably small, and the stability
offered by this approach appears to be adequate.
It can be concluded from this analysis that for many
experiments the accuracy and stability afforded by this
measurement concept is adequate. It may also be concluded
that it is at least as accurate as currently popular alternate
concepts, while enjoying a significant circuit simplicity,and
a considerable advantage in power consumption.
E. Packaging Technique
Figure 7 illustrates a prototype package with a pressure
sensor and a flow probe attached. Each amplifier, voltage
regulator, power controller, and oscillator was assembled and
potted, then interconnected within the package. The package
was fabricated from cast acrylic and the cover was attached
by stainless steel screws and sealed with an O-ring. The
pressure sensor and flow probe were attached to the package
by removable miniature connectors. Used with a 160 ma hour
battery, the unit pictured will operate continually for
approximately 80 hours. With the controller set to 4 minutes
there is a potential of 1200 actuations. At an average of two
recording events per day, an operating life of nearly two
years is available. Shelf life of power supplies at the
elevated temperature is likely to be a limiting condition.
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Each module is assembled from a breadboard circuit by
using cordwood techniques. The components are epoxied
together, each making direct contact with adjacent components.
Interconnection between components is made by a small gauge
wire. Each module is then potted in a 16 x 10 x 12 mm volume.
These modules are then interconnected as appropriate with
required e:,ternal components placed. between the leads. The
package sensor connections are brought to a bulkhead connector
in the package and the sensors are mated to these bulkhead
connectors by sealed plugs. Adjustment potentiometers are
enclosed within the package. Prior to implant, exposed
portions of the modules and the battery are covered with
beeswax. This furnishes additional protection against leaks.
F. Evaluation
Testing this package and a similar prototype package has
been accomplished during the past two years. There have been
few problems associated with pressure measurement during this
period, for an earlier program using the sensor and external
electronics had eliminated most of them.
During this testing period, several problems associated
with the flowmeter have been discovered and solved. Clearly,
a rugged probe is necessary for structural and electronic
stability and for consistency of calibration. The ultrasonic
flow probe is a thick-walled acrylic tube with crystals placed
at a 30-degree angle to the direction of flow. A slit in the
tube allows the vessel to be placed between the crystals; the
slit is closed by a press-fit slug. The leads to both cr";-
tals ema.nate from the cylinder tangentially to the circumfer-
ence and opposite to the gate.
Implant technique is straightforward; it consists first
of exposure of the renal and abdominal vessels via a longi-
tudinal blank incision. The flow probe cavities are filled
with gel foam, the probe is then placed about the renal
vessel, and the small gate inserted to retain the vessel
within the probe. The gel foam aids in tissue growth,
shortening the grow-in time. The pressure sensor is inserted
through a small incision in the abdominal aorta and sutured
in place. A dacron patch encircling the entire vessel aids in
anchoring the transducer. The package is sutured against
the abdominal wall.
Pressure signals are of a high quality immediately
postimplant; however, about four days are required for quality
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flow signals to be received as a finite length of time is
required for the flow probe to grow in. It has been found
that fibrous tissue anchors the sensor and the package very
firmly, and after two weeks, considerable effort is required
to extract the equipment. To date an implant life of four
months has been achieved.
Flow calibration is accomplished prior to implantation
by placing the probe in a fixture and forcing known quantities
of fluid through in varying times. The nominal sensitivity is
0.1 volt output per ml/sec. However, flow calibration can be
conclusive only if it is actually carried out with the probe
on the vessel. This is not easy but can be accomplished in
the case of the kidney vessels by comparing the mean renal
artery flow, as determined by the implanted probe and elec-
tronics, with a collection of the flow from the renal vein
during the same period. A second technique, which can be
conducted at the end of experimentation, is to cut the renal
vessel and force fixed amounts of fluid through the vessel in
a known time. This allows a fairly 'satisfactory calibration
if air can be-excluded from the blood that is being forced
through the vessel. A combination of preimplant calibration,
proper scaling for vessel diameter, and confirmation by either
one or both of the in vivo techniques yields a calibration
factor which is sufficiently accurate to be meaningful.
Pressure calibration is also conducted prior to implantation
by standard manometric techniques and periodically verified
by cannulation techniques after implantation.
A variety of methods of affecting renal blood flow have
been utilized in assessing the applicability of this implant-
able telemetry system for chronic studies. They have included
psychosocial stressors, pharmacological agents, and treadmill
exercise. An exercise episode will suffice to illustrate the
application of the device and to substantiate its utility.
Before exercise, an implanted dog was held in the obedience
training "stand-stay" position on the treadmill for 3 minutes.
Exercise consisted of running on a 15-degree incline for
3 minutes each at 2 and 3 miles per hour, and for 5 minutes at
4.5 miles per hour; then back to 2 miles per hour for 3 min-
utes, followed by 3 minutes of "stand-stay" on the treadmill.
Typical results are illustrated in Fig. 8. For this dog mean
pressure fell at the onset of exercise with perhaps a slight
increase in mean blood flow. Pulse pressure fell while pulse
flow increased. Throughout the course of the exercise mean
pressure increased and mean flow decreased, while pulse pres-
sure remained substantially unchanged and pulse flow increased.
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Figure 8. Data Obtained from an Exercise Event.
An instrumented dog was exercised on a treadmill inclined
at 15 degrees sequentially at speeds of 2, 3, 4.5, and
2 mph for respective periods of 3, 3, 5, and 3 minutes.-
Three-minute control periods p eceded and followed exer-
cise. ?rom taped dynamic pressure and flow, mean pressure
and flow were electronically calculated and the absolute
resistance to flow determined by electronically dividing
mean pressure by mean flow. The time rate of pressure and
flow change was electronically generated to aid in analysis
of the hydraulic impedance. One apparent conclusion is
that at the start of exercise mean renal flow remained
constant as a consequence of vasodilatation but throughout
exercise decreased because of vasoconstriction. The
increase in df/dt postexercise relative to preexercise
indicates an increasing system compliance.
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Since mean flow decreased and mean pressure increased, the
absolute value of the resistance to flow increased. Also at
the onset of exercise, df/dt increased and dp/dt remained
constant; while throughout exercise, both df/dt and dp/dt
increased. At cessation of exercise, mean blood pressure
increased, mean flow remained at the lower level established
during exercise, and the pulse flow returned to a level above
that at preexercise. The rate of flow change df/dt and the
rate of pressure change dp/dt both returned to substantially
the same level existing at preexercise. From these observa-
tions certain conclusions can be made and certain evidence
gathered supporting cortical-to-medullary flow shifts. These
results indicate a definite decrease in resistance to renal
blood flow at the beginning of exercise, followed by an
increase in resistance as exercise continues. This renal
blood flow pattern would seem to correlate with the recent
work of Stinson et al. (1969) who have demonstrated choliner-
gic vasodilatation during the reduction of mean renal arterial
pressure. It can further be noted that probably, as a func-
tion of the severity of exercise and the concomitant increase
in oxygen consumption of the exercising muscles, there is an
increased resistance to renal blood flow, an increased heart
rate, and an increased mean blood pressure--all of which
reflect increased metabolic demands (Krutz et al., 1971).
Evidence for the cortical-to-medullary flow shift can
be gathered by considering the characteristics of the flow
throughout the exercise episode. For a rough approximation,
flow to the kidney (Spencer and Denison, 1963) can be defined
by
f = C dp + E
dt R
(36)
where f is flow in ml/sec, p is pressure in dynes/cm2; C is
compliance defined by 2Fr3 /Ekt*; r is the vessel radius; t is
vessel wall thickness; £ the segment length; and E the modulus
of elasticity; R is resistance defined by 8nr1/lr4 , where q is
the blood viscosity. The factor df/dt is thus defined by
f =c d2 + 1 dp
dt dt R dt
*It may be that compliance is defined by 2 E r 3
Et
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On the basis of Eq. 36, at the onset of exercise since there
was a decrease in systolic pressure, but initially no change
in maximum dp/dt, yet there was an increase in maximum flow
and a decrease in minimum flow, it would appear that C
increased and R remained unchanged; or R decreased and C
remained unchanged; or both C increased and R decreased.
Comparison of a term labeled systolic resistance determined
during systole where dp/dt is zero illustrates that the
resistance has decreased from its preexercise value. And
since C is also proportional to the radius r, it would seem
probable that the compliance has also increased.
One can also argue that at the onset of exercise, the
increase in df/dt described by Eq. 37 is a consequence of
decreasing resistance and increasing compliance as dp/dt did
not increase. A decrease in resistance and consequently an
increase in the effective flow radius can be confirmed by
considering points where dp/dt is zero, where the first term
in Eq. 36 is zero. Resistance determined at this point on
the cardiac cycle by dividing the pressure by the flow yields
a lower value shortly after start of exercise than for corres-
ponding points determined during preexercise; and by consider-
ing Eq. 36, during a very short section of systole where the
change in pressure is small, but the rate of pressure change
is large, an estimate of the compliance value can be made.
The first term in the equation is then closely related to the
delta flow. This term is a product of the compliance and the
rate of pressure change; thus if dp/dt does not change frown
preexercise to shortly after exercise, but the pulse flow
increases, it must be argued that the compliance increasec.
Figure 8 illustrates that dp/dt 6cid not increase in the
transition from "stand-stay" to exercise, but the pulse flow
did increase. The compliance therefore must have increased.
As exercise continues, the mean resistance increases
which implies decreasing radius and therefore a decreasing
compliance; yet the pulse flow remains high or increases
relative to preexercise values. These observations must be
considered in light of the fact that dp/dt also increases
during this period. Equations 36 and 37 indicate that the
character of the flow is influenced to a substantial degree by
dp/dt. Thus the direction of capacitance from shortly post-
exercise to near completion of exercise cannot be reliably
deduced without an extensive analysis of magnitudes.
Postexercise, the mean flow is definitely down relative
to the start of exercise in the face of a relatively elevated
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pressure level. Pulse flow has decreased to slightly above
preexercise levels and slightly below onset of exercise
levels. The resistance value as judged by the minimum flow
level has certainly increased from preexercise, allowing a
conclusion that the effective radius has decreased. At post-
exercise peak dp/dt has returned to its preexercise value,
but the capacitive component of flow determined at onset of
systole is as large or larger than preexercise values. This
would lead to the conclusion that the compliance has increased
or at least remained unchanged over preexercise levels. But
how can this be if the effective radius has decreased? Con-
sideration of Eq. 37 tends to confirm this conclusion. The
rate of change of flow postexercise is greater than that at
preexercise, but the value of the resistance has increased,
and the level of dp/dt pre- and postexercise is nearly equal.
This means that the second term in Eq. 37 is smaller during
postexercise cardiac cycles than during preexercise cycles.
Therefore if df/dt at pre- and postexercise is equal, then the
downward increment induced by an increasing resistance has to
be nullified and overcome by an upward increment in the
compliant flow term. If dp/dt has not increased, then compli-
ance must have increased relative to its preexercise value.
A decrease in effective flow area through the kidney without
a concomitant decrease in compliance appears inconsistent with
traditional concepts of hemodynamic impedances. But it could
occur if flow shifted from many cortical vessels to fewer,
larger-diameter, more compliant vessels in the medullary area
of the kidney.
It is appreciated that the arguments presented in sup-
port of theories suggesting a shift from cortical to medullary
flow are circumstantial. Direct evidence is necessary to
support these contentions. Howeve: this argument has been
presented as an example of an application of telemetry and to
justify our removing it from a device still in the develop-
mental stage to one having useful applications. Indeed
because of the role the kidney plays in fluid volume regula-
tion it can be argued that the research application of
telemetry of the type just described is quite valuable in
orbital animal experiments. If direct evidence can be obtained
to support the impedance concepts presented above, then one
has a valuable indirect measurement of renal responses which
could be applied to research in renal function in unrestrained
subjects.
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G. Circuit Values
Circuit values are tabulated in this section to aid
those who may wish to fabricate portions of the described
telemetry system. Generally, 5% resistor and 10% capacitor
values have been employed; thus the listed values should be
used principally as a guide. These components which are
likely to need further adjustments are noted with an asterisk.
Carrier Oscillator (Fig. 1)
(Capacitance in pf; resistance in KQ ; inductance in ph unless
otherwise noted)
R5 - 270
R6 - 8.2
R7 - 3.9
R8 - 1.5
C2 - 1.5 pf
C3 - 7
C4 - 33
C5 - 33
L1 - 5.5t #18 copper wire 3/16 dia
RFC1 - WE-WE minaductor 0.82 ph
RFC2 - WE-We minaductor 0.82 ph
Q3 - 2N 918.
Blood Flow - Subcarrier Oscillator (2300 H2) (Fig. 2)
(Capacitance in pf; resistance in KQ ; inductance in ph unless
otherwise noted)
Rll -
R12-
C1 -
C2 -
C3 -
C4 -
C5 -
C6 -
C7 -
Q1/Q2 -
390
24
300
300
30G
300.
1000
1 f
2200
SP8888A - dual flat pack
*Adjust limit frequencies by varying R8 and R 1 0.
R1
R2
R3
R4
R5
R6
R7
*R8
R9
*R10
- 330
- 220
- 220
- 220
- 220
- omit
- 390
- 51
- 8.2
- 68
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R.F. Switch (Fig. 3)
(Capacitance in pf;
otherwise noted)
resistance in KQ ; inductance in ph unless
R1 - 270
R2 - 5.1
R3 - 7.5
R4 - 5.1
R5 - 1000
R6 - 51
R7 - 430
R8 - 200
R9 - 6 meg
R10 - 560
Rll - 51
R12 - 2.4
R13 - 390
R14 - 0.1
R15 - 0.1
Cl - 1000
C2 - 470
C3 - 300
Blood Pressure with
C4
C5
C6
D1
SCS1
SCS2
Q1/Q2
Q3/Q4
L10
Co
Oscillator
- 100
- 15 pf
- 0.02
- D6 - FDN666
- 3N84
- 3N84
- MD6001F
- SP8888A
Pancake coil wound to
resonate at desired
frequency (approx. 500 KH)
(3900 H2) (Fig. 4)
(Capacitance in pf;
otherwise noted)
resistance in KU ; inductance in ph unless
R18 - 220
R19 - 220
R20 - 51
R21 - 220
R22 - 4.7
R23 - 220
R24 - 62
R25 - 220
R26 - 220
R27 - 24
R28 - 220
C1 - 1000
C2 - 2200
C3 - 0.022 pf
C4 - 0.33 pf
C5
C6
C7
C8
C9
C10
Cli
C 12
C13
C14
C15
D1
SCS1
Q1/Q2
Q3/Q4
Q5/Q6
- 2200
- 0.022 pf
- 0.33 Pf
- 180
- 560
- 180
- 1 Pf
- 180
- 1500
- 180
- 0.01 pf
- D5 - FDN666
- 3N82
- MD2219 - dual flat pack
- MD2904 - dual flat pack
- SP8888A - dual flat pack
Resistor Rc
R17 control
controls sensor drive current, resistors R1 2 and
modulation sensitivity and resistors R 2 0 and R2 4
control limit frequencies.
0
R1 -
R2 -
R3 -
R4 -
R5 -
R6 -
R7 -
R8 -
R9 -
R10 -
Rll -
R12 -
R13 -
R14 -
R15 -
R16 -
R17 -
0.047
30
3
5.6
15
0.091
0.2
2
2
220
220
0.2
2
2
220
200
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Blood Flow without Oscillator (Fig. 6)
(Capitance in pf;
otherwise noted)
resistance in KQ ; inductance in ph, unless
R1 - 0.1
R2 - 0.18
R3 - 0.18
R4 - omit
R5 - 51
R6 - 220Q
R7 - 2.4
R8 - 1.5
R9 - 2.4
R10 - 15
Rll - 0.510
R12 - 0.510
R13 - 0.100
R14 - 2.4
R15 - 20 K
R16 - 0.100
R17 - 24
R18 - 51
R19 - 1.5
R20 - 1.2
R21 - 27
R22 - 0.110
R23 - 9.1
R24 - 10
R25 - 0.100
R26 - 0.510
R27 - 0.100
R28 - 0.510
R29 - 0.100
R30
R31 - 1.2
R32 - 2.4
R33
R34
R35
R36
R37
R38
R39
R40
R41
R42
R43
R44
R45
R46
R47
R48
R49
R50
R51
R52
R53
R54
R55
R56
R57
R58
R59
Cl
C2
C3
C4
-9.1
- 10
- 0. 100
- 0.510
- 0.100
- 0.510
- 0. 100
- 0.100
-1.2
-2.4
- 15
- short
0.056
- 0.500
- 0.560
- 0.051
- 0.056
- 0.051
- 0.051
- 0.560
- 0.150
- 0. 100
- 1
- 0.100
- 10
- 10
- 330
- 0.02 pf
- 0.02 pf
- 15 pf
- 100
C5 1000
C6 - 470
C7 - 15 pf
C8 - 1000
C9 - 330
C10 - 180
Cll - 15 pf
C12 - 560
C13 - 47
C14 - 180
C15 - 1800
C16 - 15 pf
C17 - 150
C18 - 47
C19 - 47
C20 - 180
C21 - 1800
C22 - 15 pf
C23 - 150
C24 - 47
C25 - 22
C26 - 2700
C27 - 330
C28 - 3300
C29 - 15 pf
C30 - 33'0
C31 - 4700
C32 - 0.Y. pf
C33 - 15 pf
Dl-D18 - FDN666
SCS1 & SCS2 - 3N84
All NPN transistors are MPS 6515 and PNP MPS 6519.
C
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III. Cardiovascular Research Applications
A. Introduction
The sympathoadrenal system complex is responsive to a
variety of psychological and physiological factors which via
alteration& in renal impedance cause variations in fluid and
electrolyte balance. Thus superimposed upon the autoregula-
tory phenomenon in the kidney lies a rapidly acting neural-
endocrine control mechanism which also influences renal
functions. In much of the renal research in the past plasma
clearance techniques have been used to measure renal para-
meters, such as renal blood flow and glomerular filtration
rate. This technique is employed routinely in current renal
research. Because of the nature of the measurement the
results are an average value, the data is obtained during
restraint and/or anesthesia, and the segmental renal resist-
ances and compliances can not be determined. Within the past
decade, research in renal circulation has benefited from the
ability to measure dynamic flows and pressures. Analysis of
this data has typically considered mean flow and pressure as
a means of assessing renal responses to selected stimuli.
Recent work with simultaneous pressure and flow measure-
ments in dogs has shown that wave shapes and amplitudes can be
used to estimate values of these renal vascular compliances
and resistances. This technique permits the total renal
resistance to be separated in pre- and postglomerular compo-
nents and the renal artery compliance to be determined. From
the pre- and postglomerular resistance values the glomerular
filtrat.on pressure can be estimated. It is believed that
these relationships provide an indicator of change in renal
hemodynamics which is more revealing than either mean pres:ure
and flow responses or the plasma clearance measurements. In
both the renal and the general circulation resistance and
compliance values affect short term control of blood pressure
and the long term control of both fluids and electrolyte
balance and blood pressure. On a short term basis neuro-
stimulation results in elevation of blood pressure because of
a general vasoconstriction of the vascular system. Chronic
neurostimulation leads to a thickening vascular wall and to a
reduction in lumen diameter and potentiation of the smooth
muscle response to sympathetic stimulation. Also tissue
nutrition may be impaired by high systemic blood pressure
because of sclerotic development in the small arteries. In
this case, sclerotic development may be exacerbated by local
regulatory mechanisms which call for an increased pressure to
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overcome the nutritional impairment evoked by sclerotic
development (Henry and Meehan, 1971). The renal system can
be implicated as a factor in many cases of hypertension.
However it is difficult to say if it is a primary factor in
inducing hypertension through the renin-angiotensin-aldosterone
loop or a secondary factor evolving from impairment induced
by sclerosis and smooth muscle potentiation.
The application of implanted telemetry for chronically
monitoring systemic blood pressure and renal flow permits
quantification of hemodynamic components of the renal vascular
bed in unrestrained dogs which may aid in establishing the
genesis of hypertension. It is suggested that these component
values can be used as indices of renal function, levels of
autonomic arousal, level and location of renal atherosclerosis,
and further because of the apparently differing effects neuro-
genic and hormonal influences have on the component values,
i.e., there are indications that control of preglomerular
resistance is both hormonal and neural whereas control of
postglomerular resistance is primarily hormonal, an assessment
of the relative contribution of the neurogenic hormonal factors
operating in a given situation may be made.
B. Renal Hemodynamic Model
Blood flow in the kidney is through multiple individual
channels branching from the interlobular artery. These chan-
nels are similar in anatomical arrangement but vary in
diameter, in length, and in the relative amount of collagen
and elastin. In each channel the first major resistance s:.te
is encountered at the afferent aiteriole vessel which branches
from the interlobular artery and opens into the glomerular
capillary. This capillary has a large surface area and behaves
hydraulically as a large diameter storage volume and stores a
large volume at a low pressure. On the exit side of the
glomerular capillary but prior to the peritubular capillary,
the efferent arteriole in parallel with the effective tubular
resistance forms the second major resistive site. Downstream
from the compliant peritubular capillary, a third resistive
area is encountered. From this third resistive site the flow
channels join the interlobular vein. The renal artery with
its smaller branching supply vessels and the renal vein with
its associated smaller connecting vessels add a resistance
and a compliance which precede and follow all the elements
created by the multiple parallel flow channels. Figure 9
illustrates a proposed hydraulic equivalent of one flow 0
channel originating at the interlobular artery and terminating
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in the interlobular vein (Rader et al., 1972). In terms of
the pressure at the afferent arteriole and the pressure in the
glomerular capillary, the flow through one of the many affer-
ent arterioles and into one of the many compliant elements is
respectively:
far = Pi - Pg'
Ra'
fac = Ci' Pi*
(1)
where Pi is the first time differentiation of Pi. The sum of
"n" of these individual flows where it is assumed that Pg' and
Ra' and Ci' are equal to their respective counterparts in each
individual flow channel is:
fa 1 + fa2 + fa3 .... +fan = nCi' Pi + Pi - Pg'
Ra'/n1
(2)
Also since in each channel the flow through Ra must equal the
compliant and resistive outflow at the node where Ra' joins
C'g, it can be stated that:
Pi - Pg g' f I Pg' - Pp
R'a Cg Pg + R t
(3)
where R't is a composite of R'e, R'g and R'p.
The total flow in one kidney is the sum of flow in all
channels.
If there are "n" identical channels it follows that:
Pi - P'g = nC'g P'g + P'g - P
R a/n Rlt/n
(4)
Equations 1 through 4 substantiate that the many parallel
flowpaths can be combined into a single flowpath where each
discrete resistance is divided by and each compliance is
*Compliance is defined as change in volume Q per change
in pressure P. Thus C = dQ/dP. Manipulation and division by dt
gives C dP = dQ; but dQ/dt is flow f, therefore f = C dP.
dt dt dt
.
.. ' Re' .
P VASCULAR Pc
INTERLOBULAR INTERLOBULAR
ARTERY VEIN
I i
Figure 9. Hydraulic representation of a kidney.
Flow is through multiple channels of similar structure.
P's are pressures in mm Hg; C's are compliance in
ml/mm Hg; R's are resistances in mm Hg/ml/sec.
C'i is the individual compliance in each arteriolar
vessel.
R'a is the individual afferent resistance.
C'g is the individual glomerular capillary compliance
R'e is the individual efferent arteriolar resistance.
R'g is the individual filtration resistance.
R'p is the individual absorption resistance.
C'p is the individual peritubular capillary compliance
R'c is the individual postcapillary resistance.
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multiplied by the number of parallel paths. An electronic
model of an ideal kidney is illustrated at the top right in
Fig. 10. The component values illustrated represent compos-
ites of all individual component values in each flowpath. The
resistance offered by the larger supply arteries and collect-
ing veins is thought to be small in comparison to the afferent
arteriolar resistance and for a first approximation are
neglected. The compliance contained in the renal artery and
smaller arterial supply vessels is lumped with the compliance
represented by Ci. In the present model, mass of blood in the
renal supply vessels is also neglected and it is assumed that
the resistance and compliance does not vary with pressure.
Flow into this model is then the sum of the flow into
the storage element preceding the afferent arteriole and of
that through all the afferent arterioles. This can be formu-
lated as:
f = Ci Pi + Pi - Pg
Ra
(5)
where P? is the first time differential of Pi. The character
of the instantaneous pressure, Pi, the time rate of pressure
change Pi and the instantaneous flow f are illustrated on the
left in Fig. 10. The first differential of Eq. 5 yields:
= Ci Pi+ Pi Pg
Ra Ra
(6)
where the double dot indicates thel second time differential.
The time rate of flow change f is illustrated at the bottoi-
left in Fig. 10. In the bottom right of Fig. 10 salient
points of the model development are summarized. Because of
the buffering effect of the large glomerular compliance in
series with the afferent arteriolar resistance, the factor
Pg/Ra may be neglected for steep incremental pressure changes
in Pi. On the basis of a comparative cross-sectional area
listed by Thompson (1970) it is probable that the glomerular
compliance is on the order of 100 times the supply vessel
compliance. The value of the supply vessel compliance has
been estimated as nominally 0.002 ml/mm Hg. The afferent
arteriolar resistance is nominally 10 mm Hg/ml/sec, and at
1 Hz the glomerular capillary reactance is approximately
0.8 mm Hg/ml/sec; hence, the assumption that Pg is negligible
Ra
for high frequency components appears valid. Therefore during
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Figure 10. Renal parameter estimation technique.
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tabulat.-s the equation and presents assumption and
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rapidly changing small segments of input pressure, where Pg
can be assumed to be negligible, the following equation
results:
f = C Pi + -
Ra
(7)
At the inflection point on the systolic portion of the input
pressure, marked by the left hand dashed line in Fig. 10, Pi
is a positive maximum and Pi is therefore zero. Thus the
afferent arteriolar resistance Ra can be calculated by divid-
ing the value of Pi by the value of f at the inflection point.
Therefore:
Ra P
(8)
Equation 8 yields an estimate of the-effective resistance
preceding the glomeruli. This resistance is considered to be
principally embodied in the afferent arterioles but, as pre-
viously mentioned, a small portion is also associated with
the renal connecting vessels.
The mean flow for one cycle as defined by f is:
1 i d (Pi - Pg) d
T2- T1 Ra
where T 1 - tim ] (9)
where T 1 is time at the start and T 2 the time at the end of a
cycle. Assuming that the pressure at T 1 equals the pressure
at T2, the contribution of the compliant element vanishes.*
2 Ci P (t) = Ci P(T2) - Ci P(T1) but P(T1) = P(T2)
f T1
Ci P(t) = O
T1
1
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With proper substitution Eq. 9 can be simplified to:
T2
fRaRtRc (Pi - Pv) dtRa + Rt + Rc T2 _ T1
(10)
The mean resistance R is defined by the mean pressure gradient
across the kidney divided by mean flow. Mean pressure across
the kidney is the bracketed portion of Eq. 11. Performing
the integration yields
_ Pi - Pv = Ra + Rt + Rc
(11)
where Ra is the preglomerular resistance, Rt is the composite
of the filtration resistance Rg, the absorption resistance Rp
and the efferent arteriolar resistance Rc and where Rc is the
postperitubular capillary resistance. Therefore by dividing
mean difference pressure across the kidney by mean flow one
obtains the sum of the three resistance values. The combina-
tion of Eqs. 8 and 11 yields a value for the postglomerular
resistance Rb of:
Pi - Pv Pi
PE = Rc + Rt= - .
f fi
(12)
The mean ;alue of the glomerular capillary pressure Pg is a
function of these resistances and .-ressures as follows:
-g = Pi Rb + Pv Ra
R R
(13)
The second factor in Eq. 13, Pv Ra,/R, is normally about 2 to
3 mm Hg while the first factor is about 70 mm Hg; thus
neglecting the second factor in Eq. 13 in some case is permis-
sible. The value of Pg as determined from Eq. 13 can be
checked by using Eq. 5 at points where Pi is zero. Such
points occur at peak systole and at end diastole and on occa-
sions in mid systole and diastole. At such points the
instantaneous flow is:
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f = Pi - Pg
Ra
(14)
Solution for Pg at systole, end diastole, and for algebraic
mean results in the following:
Pgs = Pis - fs Ra -- systolic
Pgd = Pid - fd Ra -- diastolic
Pga = Pgs + Pgd -- algebraic mean
2
(15)
where "s" and "d," respectively, refer to peak systole and
end diastole. Because the resistance Ra decreases with
increasing pressure it is probable that the estimate of Pgs
is low and that of Pgd is high. The average of Pgs and Pgd
can however serve as a check on the estimated mean glomerular
capillary pressure.
From the model glomerular filtration rate (GFR) for one
kidney can be defined as:
GFR = Pg - Pp
Rg + Rp
(16)
where Pg and Pp are respectively the glomerular filtration
pressure and the tubular capillary pressure, and where Rg
and Rp are resistance factors relating to glomerular and
tubular capillary permeability. It_may be valid to assume
that the three factors Rg, Rp, and Pp are constant for
many normal situations (Gomez, 1951). To determine the
sum Rg and Rp it is necessary to obtain the GFR by renal
plasma clearance techniques durl.Ig which time the average
glomerular filtration pressure i~ also determined. With -
the value of Rg + Rp established the instantaneous glomer.-
ular filtration rate can thereafter be directly determined
from the instantaneous glomerular filtration pressure.
The glomerular filtration pressure is available on a
beat-to-beat basis and therefore the glomerular filtration
rate is available on a beat-to-beat basis. Inspection of
Eq. 7 also reveals techniques for determining the value of
Ci. First at points where f is zero, RaCi can be deter-
mined from:
Ra Ci = - Pi/Pi
(17)
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Since Ra is known Ci can be calculated. Second, at points
where Pi is zero Ci is defined by:
Ci = f/Pi
(18)
This calculation point is marked by the right hand dashed line
running through the curves in Fig. 10. Thus from measured
values of pressure and flow, Ra, Ci, Rt + Rc, and Pg can be
derived. Pg furnishes an estimate of instantaneous glomerular
filtration rate. The compliance, Ci, yields information about
the rigidity of the vascular walls. Since Ra is inversely
proportional and compliance directly proportional to a power
function of the conduit diameter, as resistance increases
compliance decreases. This yields a valuable check on the
directional changes in Ra. The elasticity of the vasculature,
a major determinant of compliance, is influenced by the basic
structure of the vessel walls and by the degree of smooth
muscle activation. Arteriosclerosis modifies both the basic
structure of the vessel walls and the amount of smooth muscle
present. Thus the development of arteriosclerosis and athero-
sclerosis cannot be distinguished from sustained smooth muscle
activation. However in the absence of smooth muscle activa-
tion the natural compliance can be determined and used as a
measure of sclerotic development. Hinshaw et al. (1960) have
suggested indications that the afferent arteriolar resistance
may be mainly mediated by neurogenic factors, whereas, the
efferent resistance may be mainly mediated by hormonal
factors. These observations further suggest that segmental
resistance values might be used to differentiate neurogenic
and hormonal factors.
C. Experimental Application in Renal Functions
Three dogs, each under different experimental circum-
stances, were used to develop and evaluate the basic concepts.
An initial evaluation of the renal model was conducted using
a dog anesthetized with 30 mg sodium pentobarbital per kilo-
gram body weight. This dog had been implanted with a 6 mm
lumen diameter flow probe several weeks prior to the experi-
ment. Flow data was obtained by exteriorizing the connector
and mating it to external electronics. Zero flow was estab-
lished during injection of high concentrations of antiotensin
amide. Pressure was obtained near the junction of the renal
artery and the abdominal aorta via a P.E. 190 catheter
connected to a P23 Db pressure transducer. Wave shapes and
parameter values obtained during injection of angiotensin
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amide and acetylcholine are shown in Fig. 11. The pressure
and flow wave forms are shown above each sequence. In this
case Ra was determined by dividing peak Pi by peak f. This
yields a value of Ra somewhat lower than that resulting from
strict use of Eq. 8.
Under anesthesia a mean arterial pressure of 132 was
recorded. Injection of acetylcholine resulted in an afferent
resistance decrease to about 36% and a postglomerular value
increase of 216% of the control value. The total resistance
(R) remained unchanged. Angiotensin amide produced an
increase in all resistance values. The calculated mean
glomerular capillary pressure varied throughout the experiment
from 54 mm Hg to 104 mm Hg. Glomerular filtration rate was
calculated from Eq. 16 using an assumed value for Rg of
70 rmn Hg/ml/sec (1.17 mm Hg/ml/min).
Figure 12a illustrates values obtained frcm a dog that
was fully instrumented with an implantable pressure and
flow telemetry system. This experimental sequence was
designed to induce progressively increasing autonomic stimu-
lation from control through avoidance behavior. In this case
avoidance behavior was defined as the animal's reaction to
the prospect of having the implant site touched. As the
stimulation increased, the values calculated for all resist-
ances increased. However the ratio of postglomerular to the
total resistance did not change sufficiently to prevent an
increase in the glomerular capillary pressure. With the
assumption that Rg, Pt, and E remained unchanged this stimu-
lation caused an increase in the glomerular filtration rate.
As compared to control value, the value calculated for Ci
decreased for both the obedience training and the avoidance
episode. The increase in Ci from obedience training to
avoidance is probably associated with the increased pressure
and thus an expansion of the vessel diameter preceding the
afferent resistance site.
Figure 12b illustrates the recording obtained from this
same dog at 0300, 0400, and 0500 hours during a period when-
records were taken each hour for a 24-hour period. The large
amplitude, sharp flow characteristics tended to occur from
1100 to 0500 hours. The 0200-hour recording illustrates a
period of low afferent resistance, the 0300-hour recording a
period of low afferent resistance changing to a period of high
afferent resistance, and the 0400-hour recording illustrates
a period of sustained high afferent resistance. Although the
value for compliance is not shown, inspection of the flow wave
forms confirms that compliance is higher at 0300 hours than at
0500 hours.
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Figure 12a. Progressive sympathetic arousal and
its effect on renal parameters. From control through
avoidance-reaction Ra increased to 320% and Rb to 135% of
control values. In the same sequence, Pi increased to
189% and R to. 170% of control values. Flow increased
only slightly while Pg increased to 147% of control
values. These parameter changes indicate that neuro-
control resides primarily in the afferent resistance
change; flow is well regulated, but the glomerular filtra-
tion pressure is variable.
Figure 12b. Spontaneous recordings. The left panel
illustrates a period of low afferent resistance, the
center recording illustrates a period of low afferent
resistance changing to a higher value, the right panel
illustrates a period during which the afferent resistanc.-
was sustained at a high level.
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Figure 13a illustrates data obtained from a third dog as
he was recovering from halothane anesthesia following implan-
tation of the electronics package. Under halothane a low
afferent resistance value was calculated, whereas after
partial recovery and when the subject was on ambient air, a
large value of afferent resistance was calculated. Figure 13
shows tracing and resultant data obtained from this same dog
at 2200 hours and at 1015 hours during a 24-hour data record-
ing. The data taken at 2200 hours is indicative of a
relatively dilated vascular system in contrast to the data
recording at 1015 hours which indicates vasoconstriction.
D. Pitfalls and Problems
The best currently available implantable pressure trans-
ducers have drift characteristics which prevent long term use
without periodic calibration. To reduce the magnitude of
this problem it has been the practice to employ transducers
certified by the manufacturer to have a baseline drift of
less than 6 mm Hg per month and a sensitivity drift of less
than ± 3% of the output at 200 mm Hg. 0 In our experience in
vivo sensor-drift characteristics have been somewhat greater
than specified by the manufacturer. In this work calibration
was conducted periodically by comparing transmitted pressures
with pressures obtained by direct cannulation (Stevens, 1973,
in press). A small polyethylene catheter connected to a
pressure gauge is inserted via the femoral artery up to the
level of the implanted transducer. Data is then recorded
simultaneously from the implanted transmitter and the external
pressure grauge. Systolic and diastolic pressure points on
each record are assumed to be equal, hence a pressure voltage
relationship for the transmitted data can be established.
After the catheter removal the femoral vessel is repaired with
fine sutures. This repair technique permits the calibration
procedure to be conducted on one vessel many times.
Flow is calibrated before implant by forcing fluid
through the flow probe lumen at several constant rates to
develop a voltage output as a function of quantity of flow.
An in vivo calibration is calculated by scaling the in vitro
calibration by the ratio of lumen diameter to estimated
vessel diameter. The zero baseline is estimated by injection
of large quantities of hypertensin. This causes profound
renal constriction and the minimum point on the flow during
the lowest pressure is taken as the zero flow position.
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Figure 13a. Cardiovascular response to Halothane.
The left side shows recordings taken when the animal was
on halothane and oxygen, the center is a transition period
and the right side is a recording taken after the animal
had been returned to ambient air.
Figure 13b. Comparison of renal parameter values
determined when the animal was relaxed and alert.
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Once the pressure sensitivity has been established by in
vivo calibration, the error in Ra due to an error in Pi can
be assumed to be small, as the sensitivity will generally be
less variable than the intercept. The major error in cal-
culating both Ra and R appears to be the flow sensitivity
factor. Although no statistical evaluation has as yet been
conducted, it is estimated that resistance values reported in
this work are in error by ± 25%. These errors are mainly a
product of applied techniques, not of limitations in the pro-
posed approach. Pressure calibration has probably been
realized to within ± 5% of the absolute value. However due to
the unknown internal vessel diameter, flow sensitivity is
probably in error by 20% of the absolute value. The adequacy
of establishing zero flow by angiotensin injection has been
confirmed by comparing zero flow levels in a sacrificed dog
with flow levels produced by angiotensin in the same dog.
These criteria yield an error in Ra and R of ± 25%. The
errors are in the same direction, thus the subtraction of Ra
from R to yield Rb is in error in the same direction by ± 25%.
The error in the calculated values for R, Ra, and Rt + Rc,
does not produce equivalent errors in the calculated values
for Pg and the GFR because resistance ratios are used in
these calculations and the errors tend to cancel. It appears
feasible to establish flow calibration within ± 5% of the
absolute value by producing zero renal artery flow through the
use of acetylcholine to stop the heart for a short period, or
by eliciting profound renal constriction through the use of
angiotensin, and by establishing flow sensitivity by compar-
ing values of flow measure with the telemetry system with
values measured by clearance techniques. On the basis of.
the model, resistance values can then be determined to witAin
± 10%. With this degree of potential accuracy present in
electronic techniques the adequacy of the model must be
further evaluated. In discussing the previous model it has
been assumed that the components' values do not vary with
pressure, that the components' values can be lumped, and
that the mass of blood is negligible. If the parameter varia-
tion with pressure is ignored but the mass of the blood is
included, the renal flow is given by:
f = i Pi - MCi f+ Pi - Pg - M
Ra
(19)
where M is a factor related to the mass of the blood. In the
model this would appear as an inductor preceding the compli-
ance Ci. Differentiation of Eq. 19 yields:
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= Ci Pi - MCi f
Ra Ra Ra
(20)
At points where Pi is zero, i.e., maximum and minimum
points of Pi, the first term on the right of the equal signs
vanishes. As before, it is assumed that the term Pg/Ra can
be neglected because of the, large compliance in the glomeruli.
The approximate equation for Ra when inertia of the blood is
included is thus:
Ra = Pi - M f
f + M Ci f at maximum and minimums of Pi
(21)
If M has an appreciable value, the determination of Ra by
Eq. 21 will be substantially larger than the determination by
Eq. 8. To determine Ra from Eq. 21 a value of M must be
assumed. Rothe and Williams (1972) report a value of
0.05 mm Hg - sec2/ml for M and a value of 0.001 ml/mm Hg for
the compliance Ci. Our measurements indicate that at the
point where Pi is a maximumr. i.e., at the inflection point of
Pi, the values of f, f and f are 100 ml/sec2 , -7000 ml/sec3 ,
and -700,000 ml/sec , respectively. The products M f and
M C f are -350 mm Hg/sec2 and -35 ml/sec2, respectively. The
value of Pi at this point is on the order of 800 mm Hg/sec.
Using these values, application of Eqs. 8 and 21 yields values
for Ra of 8 and 17.5, respectively. Thus, on the basis of
the approximate value listed above Eq. 8 will yield a value
for Ra on the order of 50% lower 'han Eq. 21. Since errors in
the calculated value of Ra inject errors into the determina-
tions of postglomerular resistance Rb, glomerular filtration
pressure Pg, and the filtration resistance Rg, it is important
to appreciate the possible effects of ignoring the mass of
the blood in renal hemodynamic investigations. From Eq. 20
at points where Pi = 0 with the assumption that Mf and M Ci f
are negligible the compliance is defined by: Ra
Ci = f /Pi (Pi = 0)
(22)
The estimation of Ci from Equation 22 appears to be reasonable
as neither P nor f are changing rapidly and a moderate phase
shift between f and Pi would not cause appreciable error. The
assumption that factors containing f and f can be neglected in
calculation the compliance is valid, as in the vicinity of
Pi = 0 f is nearly constant, and thus f and f are nearly zero.
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The value for Ci estimated during pentobarbital anesthesia is
considerably lower than the value estimated during unrestrained
natural activity. The value determined when subjects are
anesthetized with pentobarbital approximates that estimated by
Rothe under similar conditions. However, even though the
estimate of compliance by Eq. 22 appears to be accurate, care
must be exercised in applying Eq. 21 to determine Ra. The
curve shown in Fig: 10 illustrates that at the inflection point
of f the value of f is approximately 100. But Pi is approach-
ing a maximum rapidly, and thus Pi is approaching a zero value
rapidly. Thus any phase shifts between pressure and flow due
to sensor placement, the hydraulics of the pressure-sensing
system, or the electronics will cause a serious error in the
calculation of Ra because of the influence this has on the
value of Pi. An estimate of the minimum acceptable phase
error is available from the fact that flow rises from a
diastolic level to a peak systolic level often in less than
40 msec. Thus for reasonable results using the suggested cal-
culations. the time shift between the two parameters caused by
artifacts must be maintained quite small. The value for f
determined by integrating Eq. 19 is:
f 2 [i Pi - M Ci f + R (Pi - Pg - M fdt
T2
(23)
The integrals of the first, second, and last terms are zero.
The mean difference pressure and the resistance contribute, to
the mean. flow value and the mean: resistance R is the same.as
that in the model which neglected the mass of this blood.
Thus R is influenced mainly by errors in pressure and flow
measurement and not by model inconsistencies.
E. Discussion
The character of the flow when the effects of pento-
barbital are likely the most influential, i.e. far left and
far right, in Fig. 11 is consistent with the sympathomimetic
effect of pentobarbital. The altered character of the flow
in the case where the effects of angiotensin amide are added to
the pentobarbital is produced by even greater vasoconstriction.
The wave flow shape in this case is quite similar to the wave
shape of the pressure, indicating a very rigid renal vascular
system. Flow wave shapes occurring in constricted vessels
can be contrasted with the wave shapes generated when
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acetylcholine is the dominant pharmacologic agent. In this
case pressure and flow are both down from precontrol values.
The afferent resistance is down and the postglomerular
resistance is up. Dilatation of the afferent resistance is
likely due to the direct effect of acetylcholine on the
smooth muscle and to the cholinergic neurodilatation effect
on the kidney (Stinson et al., 1969). The mechanism causing
the increase in the postglomerular resistance is not under-
stood, but the result is maintenance of glomerular pressure in
the face of declining systemic pressure.
Figure 13a can be compared to Fig. 11 to contrast the
effects of halothane and the barbiturates. The hypotensive
effects of halothane are evident; pressure and the afferent
resistance are both low and the characteristic of the flow is
that of pulsatile flow through distensible vessels. It can
be concluded that the renal vascular system is quite compliant
under the effects of halothane. The gradual shift from the
distensible appearance to the rigid appearance during the
transformation from halothane and oxygen to ambient air is
quite noticeable. The increase in total and postglomerular
resistance is particularly large during this transition.
The three sections in Fig. 12a illustrate three degrees
of "sympathetic arousal." This degree of arousal is subjec-
tive as no measurement of neuroactivity was performed. An
important observation to be made in this figure is that the
afferent resistance values increase by a factor of 3, whereas,
the postglomerular resistance increases by only 1.3. It is
likely that these changes are mediated by neurogenic activity
as the change from the dilatated renal vasculature, as it
appears in the control section, to the constricted appearance,
as exemplified by the avoidance reaction, occurred in a mas'ter
of 8 to 12 heartbeats. This appears to be insufficient time
for adrenal medullary hormones to have played a significant
role in the responses. Figure 12b illustrates a spontaneous
change in parameters recorded on many occasions during
24-hour baseline data acquisition tests. These episodes are
characterized by a very compliant renal vasculature changing
to a considerably less compliant appearance without a notice-
able change in subject behavior. It is suggested that these
very relaxed episodes may be in synchrony with rapid eye
movement (REM) sleep.
The respiratory influence on the renal hemodynamics can
also be seen in the data illustrated in Fig. 12b. As the C
pressure decreases with the respiratory cycle the value of Ra
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also decreases. Brief episodes of a'sustained decrease in Ra
when the pressure is sustained at a low level are also evident
at several points throughout these recordings. Note particu-
larly points 2, 6, 9, and 10. During these sustained low
pressure events Ra tends to show a linear decrease in value
with time.
A shoulder on the systolic portion of the pressure wave
is seen in many dogs. For the dog called Mike this shoulder
developed after about one month of implant. After appearing
it was most evident during relaxed episodes. For the dog
called Chicken the shoulder often developed into a valley
during vasodilatation (Fig. 13a left). A question arises as
to whether this is a natural phenomenon or whether it is
associated with instrumentation artifacts. The placement of
the transducer to detect lateral pressure rather than end
pressure creates the possibility of an artifact associated
with the cooling effect of the high velocity blood flow on the
sensing elements of the transducer. Based on the placement
of the pressure sensor at 20 mm downstream from the renal
artery and a pressure pulse velocity of 4 msec, the artifact
due to a cooling effect would occur approximately 5 msec after
the peak flow into the renal artery. However this shoulder
always appears to occur several tens of msec after peak flow
velocity is attained by the kidney. This observation does
not support the contention that the shoulder is produced by
the instrumentation artifact.
O'Rourke and Taylor (1966) have also observed this
shoulder and conclude that it is a consequence of the proper-
ties of -tCe vascular system. Rothe and Nash (1968) have \
concluded that the notch is real as it produces renal flow of
the proper phase and magnitude. Our data would further sug-
gest that the shoulder is a consequence of the properties of
the vascular system as it does not appear to bear the proper
phase relationship to an artifact generated by a potential
cooling effect and furthermore its magnitude and position
appear to be closely associated with the tone of the vascular
system. As the vascular tone increases, the period of an
oscillation produced by the systolic shock wave could be
expected to decrease. This trend is apparent in Figs. 13a
and 13b where the shift in position due to changing tone is as
much as 40 msec. It appears most likely that this shoulder is
produced by reflections from bifurcations as the change in its
position with a change in tone and, thus, a change in the
pressure pulse velocity could be on the order of 100 msec.
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On the basis of the model and -the data analysis four
factors emerge: (1) postglomerular resistances are strongly
influenced by blood-borne hormonal factors but appear not to
be under strong neurogenic control, (2) afferent resistances
are under considerable autonomic control and in addition they
are sharply mediated by the exogenous circulating hormones
which were tested, (3) flow is less well regulated under
hormonal manipulation than neurogenic manipulation, and (4)
glomerular filtration rate is influenced by both sympathetic
arousal and the.more chronic hormonal factors. It also
appears that the afferent resistance occurring during very
relaxed periods approaches the value produced by exogenous
acetylcholine and by halothane anesthesia.
Folkow and Neil (1971) have reported that hypertensive
rats exhibit vascular resistances higher than normotensive
rats even at maximum vasodilatation. Thus in any particular
animal sclerotic developments could be verified by measuring
the afferent resistance when the autoregulatory phenomenon of
the kidney has been neutralized by smooth muscle relaxants.
The position of the shoulder previously mentioned might be
used as an index of the tone of the large vessels in the
systemic circulation. Thus sclerotic development in the large
vessels might be tracked distinctly from the same development
in the renal system. It also appears that a relative index
of stroke volume is available from consideration of both the
maximum dp/dt and the position of the shoulder relative to
systolic o.nset. With the assumption that the period of
oscillation in a damped oscillatory system is independent of
magnitude of shock, then the position of the shoulder is
affected only by the elasticity of the vascular system. I~Le
time rate of pressure change is a function of both the elas-
ticity of the vascular system and the stroke volume of the
heart. This can be formulated as follows:
Pi = f (AT, S.V.)
(24)
where S.V. is stroke volume, AT is time from onset of systole
to appearance of shoulder and Pi is the time rate of pressure
change and f denotes "a function of." Therefore if the
position of the shoulder remains unchanged, AT is constant,
but Pi increases, it may mean that the elasticity has not
changed, but the stroke volume has increased. If the position
of the shoulder changes, then with constant stroke volume output
Pi may have changed. If it doesn't, stroke volume has neces-
sarily changed. Thus for researching the genesis of hyperten-
sion this impedance technique appears to have particular
relevance.
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IV. Conclusions
The advantages of a telemetry system for measurement of
cardiovascular parameters has been considered in some detail.
It is clear that many-experiments can be conducted effectively
only when aided by telemetry techniques. Certainly telemetry
has a unique potential for cutting through the complex prob-
lem of separating psychological factors from the physiological
parameters under investigation. In fact, it greatly simpli-
fies the problem of carrying out physiological experiments on
conscious subjects while still controlling emotional variables.
The advantages of using remote recording in studies which
demand complete relaxation and freedom of the animal to inter-
act socially are evident. Telemetry also expands the lati-
tude for investigating the cardiovascular responses under
broad environmental conditions; and it appears that if the
effects of long term weightlessness on cardiovascular dynamics
are to be thoroughly investigated, telemetry offers an
improved approach.
The implanted miniaturized system described in this
report goes one step further in eliminating the clouding of
the data by unwanted emotional responses which are more likely
to occur in animals with external telemetry and. hardwire
procedures. Thus it permits a more valid interpretation of
the influence of the manipulated variable on physiological
functions. The implant method also allows a better definition
of normal physiological baseline conditions and eliminates
many troublesome problems associated with both hardwire and
external telemetry techniques. Tlhus the equipment described
appears !-o have widespread applicability in chronic stud-i:s
dealing with cardiovascular adjustments to various stresses.
Although the implant technique has progressed rapidly
during the past 10 years, the process of refinement is not
completed. Long term stability must be improved. For flow in
the system described there is a sensitivity imprecision
(volts/ml/sec) of near ± 10% which is related to the inability
to either measure or know absolute values of the system's
parameters, mainly the sound velocity and vessel internal
diameter, to a sufficient degree of precision. Calibration
of the entire system as a function of milliliters of blood
per second forced through a vessel similar to the vessel on
which eventual measurement will be conducted can theoretically
eliminate this imprecision. However the vessel diameter can
not necessarily be assumed to be the same in an in vivo appli-
cation; thus the calibration is not reliably translatable to
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the final flow measurement. Real sensitivity is a direct
function of the vessel diameter which varies in experimental
situations. The stability of the sensitivity, assuming a
fixed diameter, is quite good. It is mainly a function of
the system balance and the differential change in crystal
impedance. By application of the limiting concept amplitude
instabilities can be substantially reduced. Change in velocity
of ultrasound with temperature is minimal. The final con-
clusion regarding sensitivity stability is that it is a major
function of the internal vessel diameter and is reasonably
independent of other factors.
The position of the intercept (zero flow output voltage)
with voltage limits incorporated is mainly influenced by
varying crystal properties which induce differential phase
changes. It is not known what these differential phase
changes are in relation to long term aging of the crystals,
for this factor has not yet been investigated. The relative
phase change caused by temperature and media change is related
to differential variation in resistive and reactive components
of the crystals and has been experimentally determined to be
short 1% of fullscale per degree Centigrade. The output
voltage for zero flow is established when there is zero flow
of normal blood at a constant temperature.
For normal implant operation where the environmental
temperature is expected to vary little the maximum possible
change would be from 94 to 104 degcrees Farenheit; for such a
rare event, the baseline would vary by no more than 10% of
fullscale. More typical operations would yield a 3% to 6'%
precision: for baseline conditions, This stability is obt.ined
with very low power consumption ald modest circuitry. The
final conclusion is that for chronic implants, where long
term stability in conjunction with low power consumption and
small size is a requirement, the interferometric ultrasonic
flow technique is an improvement over other available tech-
niques.
Presently there appears to be no satisfactory alternate
to the miniature implanted solid state transducer for measur-
ing blood pressure. As previously mentioned in Section 1 a
total error of 12 mm Hg per month would not be unusual. This
error can be narrowed considerably in establishing calibration
by comparing transmitted pressure to pressure obtained by
cannulation.
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Implant telemetry is currently being employed in proj-
ects to determine the physiological responses to prolonged
stress, in establishing the normal for physiological values in
animals which are traditionally used in research, and in the
military sentry dog program to optimize obedience training
programs. Within the next 10 years, sensors allowing chronic
measurement of chemical constituents will be added to the
repertory. Despite high initial expense of an implantable
telemetry system, it may in the long run prove to be quite
efficient as the experimenter will be able to conduct multiple
experiments on one animal without compromise to the others.
As an example, chronic emotional stress and physical stress
studies could be conducted in parallel.
Since it is feasible to study renal hemodynamics by the
application of impedance determining techniques to measured
values of pressure and flow, one can now calculate the total
resistance to flow as well as the pre- and postglomerular
resistance values and the final outcome is an estimate of
filtration rate and an indication of neurogenic and hormonal
drive levels.
Present data suggest that neurogenic and humorally
mediated vascular adjustments will occur in response to long
term weightlessness. The renal regulation of sodium,
potassium, and water in response to a shift of blood volume to
the thorax is a proposed central factor in these adjustments.
Expansion of the atria due to the shift of blood to the
thorax results in a reduction in sympathetic outflow to the
smooth muscle of the kidney, producing a decrease in pre-
glomerulir resistance and an increase in glomerular filtration
rate. This sympathetic outflow is also responsive to a
variety of psychological and environmental stimuli (pain,
fright, exercise, restraint, etc.) which may alter fluid and
electrolyte balance through modification of renal vascular
resistance. The ability to determine specific values of renal
impedance permits the filtration pressure and the filtration
rate to be estimated and because of the differential humoral
neurocontrol it may also be feasible to determine the specific
cause of the component changes without chemical assays. In
long term orbital experiments the ability to perform renal
function studies without chemical assays has considerable
impact on weight, power, size, and reliability factors.
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